{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:11:44Z","timestamp":1784848304169,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10585-023-10237-3","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:03:30Z","timestamp":1697004210000},"page":"445-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-9465","authenticated-orcid":false,"given":"Luana Marques","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Ferreira","family":"Bomtempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeka Bustamante","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo Mota","family":"Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseu Becco","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberval Gadelha","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"10237_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3358-6","author":"N Hayashi","year":"2017","unstructured":"Hayashi N, Takahashi H, Hasegawa Y, Higuchi F, Takahashi M, Makino K et al (2017) A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-017-3358-6","journal-title":"BMC Cancer"},{"issue":"4","key":"10237_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745\u201351","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10237_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ijrobp.2011.10.018","volume":"83","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Sato Y, Serizawa T, Kawabe T, Higuchi Y, Nagano O et al (2012) Subclassification of recursive partitioning analysis class II patients with brain metastases treated radiosurgically. Int J Radiat Oncol Biol Phys 83(5):1399\u2013405. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10237_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","volume":"46","author":"E Weltman","year":"2000","unstructured":"Weltman E, Salvajoli JV, Brandt RA, De Morais HR, Prisco FE, Cruz JC et al (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46(5):1155\u20131161","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10237_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","volume":"70","author":"PW Sperduto","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70(2):510\u20134","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10237_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2014.7.GKS14980","volume":"121","author":"T Serizawa","year":"2014","unstructured":"Serizawa T, Higuchi Y, Nagano O, Matsuda S, Ono J, Saeki N et al (2014) A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified basic score for brain metastases. J Neurosurg 121:35\u201343","journal-title":"J Neurosurg"},{"issue":"1","key":"10237_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-014-1546-7","volume":"120","author":"S Lim","year":"2014","unstructured":"Lim S, Lee S, Lim JY, Park JS, Seong JS, Chang WS et al (2014) Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. J Neurooncol 120(1):199\u2013207","journal-title":"J Neurooncol"},{"key":"10237_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6548-6","author":"A Patrikidou","year":"2020","unstructured":"Patrikidou A, Chaigneau L, Isambert N, Kitikidou K, Shanley R, Ray-Coquard I et al (2020) Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-020-6548-6","journal-title":"BMC Cancer"},{"key":"10237_CR9","first-page":"372","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29:372","journal-title":"BMJ"},{"issue":"5B","key":"10237_CR10","first-page":"3015","volume":"28","author":"C Nieder","year":"2008","unstructured":"Nieder C, Geinitz H, Molls M (2008) Validation of the Graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 28(5B):3015\u20137","journal-title":"Anticancer Res"},{"issue":"3","key":"10237_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys 77(3):655\u201361","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10237_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","volume":"30","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30(4):419\u201325","journal-title":"J Clin Oncol"},{"issue":"3","key":"10237_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-012-1019-9","volume":"111","author":"M Yamamoto","year":"2013","unstructured":"Yamamoto M, Serizawa T, Sato Y, Kawabe T, Higuchi Y, Nagano O et al (2013) Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases. J Neurooncol 111(3):327\u201335","journal-title":"J Neurooncol"},{"key":"10237_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/2012.3.GKS1289","volume":"117","author":"A Likhacheva","year":"2012","unstructured":"Likhacheva A, Pinnix CC, Parikh N, Allen PK, Guha-Thakurta N, McAleer M et al (2012) Validation of recursive partitioning analysis and diagnosis-specific graded prognostic assessment in patients treated initially with radiosurgery alone. J Neurosurg 117:38\u201344","journal-title":"J Neurosurg"},{"key":"10237_CR15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.883213","author":"C Nieder","year":"2012","unstructured":"Nieder C, Andratschke NH, Geinitz H, Grosu AL (2012) Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries. Med Sci Monit. https:\/\/doi.org\/10.12659\/MSM.883213","journal-title":"Med Sci Monit"},{"issue":"1","key":"10237_CR16","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.cllc.2017.06.011","volume":"19","author":"NM Woody","year":"2018","unstructured":"Woody NM, Greer MD, Reddy CA, Videtic GMM, Chao ST, Murphy ES et al (2018) Validation of the disease-specific GPA for patients With 1 to 3 synchronous brain metastases in newly diagnosed NSCLC. Clin Lung Cancer 19(1):e141-7","journal-title":"Clin Lung Cancer"},{"issue":"32","key":"10237_CR17","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU et al (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38(32):3773\u20133784","journal-title":"J Clin Oncol"},{"issue":"8","key":"10237_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.clon.2014.03.006","volume":"26","author":"C Nieder","year":"2014","unstructured":"Nieder C, Marienhagen K, Dalhaug A, Aandahl G, Haukland E, Pawinski A (2014) Prognostic models predicting survival of patients with brain metastases: Integration of lactate dehydrogenase, albumin and extracranial organ involvement. Clin Oncol 26(8):447\u201352","journal-title":"Clin Oncol"},{"issue":"5","key":"10237_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000506954","volume":"43","author":"C Nieder","year":"2020","unstructured":"Nieder C, Hess S, Lewitzki V (2020) External validation of a prognostic score for patients with brain metastases: extended diagnosis-specific graded prognostic assessment. Oncol Res Treat 43(5):221\u20137","journal-title":"Oncol Res Treat"},{"key":"10237_CR20","first-page":"15","volume":"16","author":"V Lewitzki","year":"2019","unstructured":"Lewitzki V, Klement RJ, Hess S, Kosmala R, Nieder C, Flentje M (2019) External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors. Clin Transl Radiat Oncol 16:15\u201320","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"10237_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A et al (2017) Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). JAMA Oncol 3(6):827\u201331","journal-title":"JAMA Oncol"},{"key":"10237_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0844-6","author":"C Nieder","year":"2017","unstructured":"Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL (2017) Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA). Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-017-0844-6","journal-title":"Radiat Oncol"},{"key":"10237_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/OTT.S288928","volume":"14","author":"J Li","year":"2021","unstructured":"Li J, Jing W, Zhai X, Jia W, Zhu H, Yu J (2021) Estimating survival in patients with non-small-cell lung cancer and brain metastases: a verification of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). Onco Targets Ther 14:1623\u201331","journal-title":"Onco Targets Ther"},{"key":"10237_CR24","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.2147\/OTT.S255478","volume":"13","author":"K Chen","year":"2020","unstructured":"Chen K, Zhang F, Fan Y, Cheng G (2020) Lung-molGPA Index predicts survival outcomes of non-small-cell lung cancer patients with synchronous or metachronous brain metastases. Onco Targets Ther 13:8837\u201344","journal-title":"Onco Targets Ther"},{"issue":"12","key":"10237_CR25","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/neuonc\/noy099","volume":"20","author":"PW Sperduto","year":"2018","unstructured":"Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N et al (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the renal graded prognostic assessment tool. Neuro Oncol 20(12):1652\u201360","journal-title":"Neuro Oncol"},{"issue":"3","key":"10237_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11060-021-03793-9","volume":"153","author":"NJ van Ruitenbeek","year":"2021","unstructured":"van Ruitenbeek NJ, Ho VKY, Westgeest HM, Beerepoot LV, Hanssens PEJ (2021) Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery. J Neurooncol 153(3):527\u201336. https:\/\/doi.org\/10.1007\/s11060-021-03793-9","journal-title":"J Neurooncol"},{"key":"10237_CR27","first-page":"39","volume":"18","author":"PW Sperduto","year":"2019","unstructured":"Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D et al (2019) Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). Clin Transl Radiat Oncol 18:39\u201345","journal-title":"Clin Transl Radiat Oncol"},{"key":"10237_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-1484-9","author":"C Nieder","year":"2020","unstructured":"Nieder C, Hintz M, Popp I, Bilger A, Grosu AL (2020) Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA). Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-020-1484-9","journal-title":"Radiat Oncol"},{"issue":"20","key":"10237_CR29","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1200\/JCO.2014.58.8517","volume":"33","author":"IM Subbiah","year":"2015","unstructured":"Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-Macgregor M, Tripathy D et al (2015) Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases. J Clin Oncol 33(20):2239\u20132245","journal-title":"J Clin Oncol"},{"key":"10237_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.breast.2017.10.006","volume":"37","author":"G Griguolo","year":"2018","unstructured":"Griguolo G, Jacot W, Kantelhardt E, Dieci MV, Bourgier C, Thomssen C et al (2018) External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: a multicentric European experience. Breast 37:36\u201341","journal-title":"Breast"},{"issue":"1","key":"10237_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/cns-2017-0023","volume":"7","author":"CH Tai","year":"2018","unstructured":"Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A et al (2018) Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases. CNS Oncol 7(1):25\u201334. https:\/\/doi.org\/10.2217\/cns-2017-0023","journal-title":"CNS Oncol"},{"issue":"1","key":"10237_CR32","first-page":"1","volume":"3","author":"M Ahluwalia","year":"2021","unstructured":"Ahluwalia M, Ali MA, Joshi RS, Park ES, Taha B, McCutcheon I et al (2021) An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status. Neuro-Oncol Adv 3(1):1\u20138","journal-title":"Neuro-Oncol Adv"},{"key":"10237_CR33","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s10147-020-01740-8","volume":"25","author":"S Deguchi","year":"2020","unstructured":"Deguchi S, Nakasu Y, Sakaida T, Akimoto J, Tanahashi K, Natsume A et al (2020) Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan. Int J Clin Oncol 25:1995\u20132005","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10237_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s10147-018-1329-9","volume":"23","author":"BH Kim","year":"2018","unstructured":"Kim BH, Park HJ, Kim K, Han SW, Kim TY, Jeong SY et al (2018) Novel graded prognostic assessment for colorectal cancer patients with brain metastases. Int J Clin Oncol 23(6):1112\u201320. https:\/\/doi.org\/10.1007\/s10147-018-1329-9","journal-title":"Int J Clin Oncol"},{"key":"10237_CR35","first-page":"3015","volume":"28","author":"C Nieder","year":"2008","unstructured":"Nieder C, Geinitz H, Molls M (2008) Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 28:3015\u20137","journal-title":"Anticancer Res"},{"issue":"2","key":"10237_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ijrobp.2016.06.006","volume":"96","author":"PW Sperduto","year":"2016","unstructured":"Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A et al (2016) The effect of gene alterations and tyrosine kinase inhibition on survival and cause of death in patients with adenocarcinoma of the lung and brain metastases. Int J Radiat Oncol Biol Phys 96(2):406\u2013413","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10237_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.breast.2017.10.006","volume":"37","author":"G Griguolo","year":"2018","unstructured":"Griguolo G, Jacot W, Kantelhardt E, Dieci MV, Bourgier C, Thomssen C et al (2018) External validation of Modified breast graded prognostic assessment for breast cancer patients with brain metastases: a multicentric European experience. Breast 37:36\u201341","journal-title":"Breast"},{"issue":"4","key":"10237_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2017.06.2454","volume":"99","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA et al (2017) Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA). Int J Radiat Oncol Biol Phys 99(4):812\u20136","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10237_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.14740\/jocmr3248w","volume":"10","author":"C Nieder","year":"2018","unstructured":"Nieder C, Hintz M, Bilger A, Oehlke O, Grosu A-L (2018) Validation of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA). J Clin Med Res 10:178\u201381","journal-title":"J Clin Med Res"},{"key":"10237_CR40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/CMR.0000000000000670","volume":"30","author":"C Dalmasso","year":"2020","unstructured":"Dalmasso C, Pag\u00e8s C, Chaltiel L, Brun A, Sibaud V, Boulinguez S et al (2020) Survival estimation of melanoma patients with brain metastasis using the Melanoma-molGPA score: external validation from a French cohort. Melanoma Res 30:472\u20136","journal-title":"Melanoma Res"},{"key":"10237_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa152","author":"M Ahluwalia","year":"2021","unstructured":"Ahluwalia M, Ali MA, Joshi RS, Park ES, Taha B, McCutcheon I et al (2021) An integrated disease-specific graded prognostic assessment scale for melanoma: Contributions of KPS, CITV, number of metastases, and BRAF mutation status. Neuro-Oncol Adv. https:\/\/doi.org\/10.1093\/noajnl\/vdaa152","journal-title":"Neuro-Oncol Adv"},{"issue":"2","key":"10237_CR42","first-page":"18","volume":"4","author":"VA Venur","year":"2015","unstructured":"Venur VA, Ahluwalia MS (2015) Prognostic scores for brain metastasis patients: use in clinical practice and trial design. Chin Clin Oncol 4(2):18\u201318","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"10237_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","volume":"81","author":"J Li","year":"2011","unstructured":"Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ et al (2011) Validation and simplification of the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) classification for glioblastoma (GBM). Int J Radiat Oncol Biol Phys 81(3):623","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10237-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-023-10237-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10237-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:09:51Z","timestamp":1698746991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-023-10237-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10237"],"URL":"https:\/\/doi.org\/10.1007\/s10585-023-10237-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}